Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
synb1934 (2 trials)
Key: Synlogic (2) Acquired (2)
mrx34 (2 trials)
synb1020 (2 trials)
synb1618 (3 trials)
urea (1 trial)
atezolizumab (Tecentriq) (1 trial)
synb1353 (1 trial)
synb1891 (1 trial)
synb8802 (2 trials)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Lymphoma (Phase 1)
Phenylketonurias (Phase 2)
Urea Cycle Disorders, Inborn (Phase 1)
Trials (12 total)
Trial APIs (9 total)